FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

HALEOS LABS LTD.

NSE : SMSLIFEBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE1165.6547.25 (+4.22 %)

PREV CLOSE (Rs.) 1118.40

OPEN PRICE (Rs.) 1118.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 143

TODAY'S LOW / HIGH (Rs.)1118.40 1169.00

52 WK LOW / HIGH (Rs.)956.05 1747.85

NSE1165.0053.6 (+4.82 %)

PREV CLOSE( Rs. ) 1111.40

OPEN PRICE (Rs.) 1100.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1165.00 (14)

VOLUME 1416

TODAY'S LOW / HIGH(Rs.) 1100.00 1178.00

52 WK LOW / HIGH (Rs.)959.8 1749.65

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

1.65

Dividend Yield(%)

0.13

TTM EPS (Rs.)

66.38

P/E Ratio

17.56

Book Value (Rs.)

669.25

Face Value (Rs.)

MCap (Rs. in Mn)

3524.09

Price/Earning (TTM)

11.57

Price/Sales (TTM)

1.08

Price/Book (MRQ)

1.74

PAT Margin (%)

3.97

ROCE (%)

10.94

Incorporation Year : 31-05 2006

Management Info :

- Chairman TVVSN Murthy - Managing Director

Registered Office :

Address : Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone : 040-66288888

Email : info@smslife.in

Website : www.smslife.in

Registrars Details :

Aarthi Consultants Pvt Ltd

1-2-285 ,Domalaguda,,Hyderabad

Listing : BSE, NSE

NEWS

16Jul SMS Lifesciences India trades jubilant
SMS Lifesciences is currently trading at Rs. 1275.15, up by 131.35 point..

16Jul SMS Lifesciences India informs about r
In continuation to its earlier communication dated May 9, 2025 regarding..

16Jul SMS Lifesciences India receives EIR wi
SMS Lifesciences India has received establishment inspection report (EIR..

Financials

	QTR Jun 25	ANNUAL 25
Net Profit	51.5899999999999	213.7
Gross Profit	74.7899999999999	300.4
Operating Profit	118.46	481.77
Net Sales	790.43	3333.71

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Cohance Lifesciences (BSE)

1011.20 (9.54%)

M.Cap (Rs. in Cr)38685.19

Procter&Gamble Healt (BSE)

6525.95 (0.94%)

M.Cap (Rs. in Cr)10832.67

Glaxosmithkline Phar (BSE)

2820.85 (1.82%)

M.Cap (Rs. in Cr)47786.90

Caplin Point Lab (BSE)

2176.05 (1.86%)

M.Cap (Rs. in Cr)16540.53

Shareholding Pattern

	PROMOTERS	71.41%
	NON-INSTITUTION	28.56%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

No Data Found

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22